139 related articles for article (PubMed ID: 21125176)
1. Health-related quality of life in patients with systemic lupus erythematosus in Midwest Brazil.
dos Reis MG; da Costa IP
Rev Bras Reumatol; 2010; 50(4):408-22. PubMed ID: 21125176
[TBL] [Abstract][Full Text] [Related]
2. The relationship between disease activity and quality of life in systemic lupus erythematosus.
Khanna S; Pal H; Pandey RM; Handa R
Rheumatology (Oxford); 2004 Dec; 43(12):1536-40. PubMed ID: 15342925
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
[TBL] [Abstract][Full Text] [Related]
4. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
[TBL] [Abstract][Full Text] [Related]
5. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
6. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).
García-Carrasco M; Mendoza-Pinto C; Cardiel MH; Méndez-Martínez S; García-Villaseñor A; Jiménez-Hernández C; Alonso-García NE; Briones-Rojas R; Ramos-Álvarez G; López-Colombo A
Lupus; 2012 Oct; 21(11):1219-24. PubMed ID: 22875651
[TBL] [Abstract][Full Text] [Related]
7. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
[TBL] [Abstract][Full Text] [Related]
8. Subscale analysis of quality of life in patients with systemic lupus erythematosus: association with depression, fatigue, disease activity and damage.
Choi ST; Kang JI; Park IH; Lee YW; Song JS; Park YB; Lee SK
Clin Exp Rheumatol; 2012; 30(5):665-72. PubMed ID: 22704691
[TBL] [Abstract][Full Text] [Related]
9. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
Jolly M
J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
[TBL] [Abstract][Full Text] [Related]
10. Relationship of quality of life and physical function measures with disease activity in children with systemic lupus erythematosus.
Moorthy LN; Harrison MJ; Peterson M; Onel KB; Lehman TJ
Lupus; 2005; 14(4):280-7. PubMed ID: 15864914
[TBL] [Abstract][Full Text] [Related]
11. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
[TBL] [Abstract][Full Text] [Related]
12. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
[TBL] [Abstract][Full Text] [Related]
13. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
14. Fibromyalgia is a major contributor to quality of life in lupus.
Gladman DD; Urowitz MB; Gough J; MacKinnon A
J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
[TBL] [Abstract][Full Text] [Related]
15. [A quality of life study in women with systemic lupus erythematosus and its relation to disease activity].
Pérez-Cuevas JB; Formiga F; García-Carrasco M; Ramos M; Lara C; Rojas-Rodríguez J
An Med Interna; 1999 Sep; 16(9):457-60. PubMed ID: 10609358
[TBL] [Abstract][Full Text] [Related]
16. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
17. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic status and health in women with systemic lupus erythematosus.
Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
J Rheumatol; 1998 Sep; 25(9):1720-9. PubMed ID: 9733452
[TBL] [Abstract][Full Text] [Related]
20. [Usage of the WHOQOL-100 as a trial of objective estimation of quality of life in end-stage renal disease patients treated with renal transplantation].
Wesołowski T; Szyber P
Pol Merkur Lekarski; 2004 Sep; 17(99):260-6. PubMed ID: 15628054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
